Deals this week: eNeura, 7D Surgical, LIG Biowise

9 February 2018 (Last Updated February 8th, 2018 12:25)

eNeura Inc has secured funds through a series D funding round led by Camden Partners Nexus.

eNeura Inc has secured funds through a series D funding round led by Camden Partners Nexus.

The funds are intended to be used towards the development of its single-pulse transcranial magnetic stimulation (sTMS) device for migraine prevention.

Both the companies involved in the transaction are based in the US.

7D Surgical Inc has secured funding in a financing round.

Based in Canada, 7D Surgical is a machine-vision image-guided surgery (MIGS) system developer for spinal surgeries.

The funds will be used for the commercial launch of its MvIGS system.

LIG Biowise Ltd has secured £1.8m ($2.54m) from a series A funding round led by Phoenix Bridge and participated by other investors.

Based in the UK, LIG Biowise is a molecular diagnostics company, which proposes to use the funds towards the development of an ultra-rapid diagnostic device and advance molecular diagnostics technology.

Abcam Plc has announced a partnership with Molecular Devices LLC to develop fast and reproducible screening tools, as well as other innovative tools such as high-sensitivity fluorescent ELISA kits for researchers.

“The agreement will enable both the companies to provide better solutions for next-generation metabolomics.”

Based in the UK, Abcam is a life sciences reagents and tools developer, while Molecular Devices company is a bioanalytical measurement solutions provider based in the US.

AB Sciex LLC (SCIEX) has signed an agreement with IROA Technologies LLC to develop a labelling kit called IROA Workflow Kit.

Based on next-generation metabolomics and TripleTOF Systems, the kit improves metabolite identification in complex samples.

The agreement will enable both the companies to provide better solutions for next-generation metabolomics.

AB Sciex LLC is a US-based life science analytical technologies provider, while IROA Technologies, also based in the US, is a reagents and kits company.

Intrasense SA has signed an agreement to advance the development of MinFound Medical Systems Co Ltd’s products.

The agreement enables MinFound to use Intrasense’s Myrian platform to develop products.

Intrasense is a medical imaging software solutions provider based in France, while MinFound is a Chinese medical imaging equipment manufacturer.